Latest Senior Health news from across the web.
(MedPage Today) -- The Trump administration's nomination of Erica Schwartz, MD, MPH, JD, a former deputy surgeon general, to lead the CDC follows a review of the agency launched in January. HHS chief counselor Chris Klomp led the effort to identify...
Read full article →(MedPage Today) -- The FDA approved islatravir-doravirine (Idvynso) as a standalone, single-tablet regimen for treating HIV in virologically suppressed adults, Merck announced on Tuesday. Approval stipulates use of the oral combination in patients...
Read full article →(MedPage Today) -- As medical organizations, lawmakers, advocates -- and even the lead actor from "The Pitt" -- laud the reauthorization of the Lorna Breen Act through fiscal year 2030, they're also urging millions of dollars to boost funding...
Read full article →(MedPage Today) -- Rep. Lori Trahan (D-Mass.) during a House hearing on Tuesday expressed her frustration with HHS Secretary Robert F. Kennedy Jr., noting that he "managed to give a 'Go Gators' from the witness table, but not a 'Go [vitamin] K...
Read full article →(MedPage Today) -- At least some patients with inflammatory bowel disease (IBD) can safely use common drugs for musculoskeletal aches and pains, a large study of insurance claims data suggested, contradicting a widespread concern that these products...
Read full article →(MedPage Today) -- SAN DIEGO -- Treatment with investigational elisrasib, a next-generation KRAS G12C inhibitor, showed efficacy in patients with advanced non-small cell lung cancer (NSCLC) with and without previous exposure to other KRAS G12C...
Read full article →(MedPage Today) -- The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in a national escalation of anti-fraud efforts that have so far largely focused on specific states, Mehmet...
Read full article →(MedPage Today) -- Real-world data suggested the dual GLP-1/GIP receptor agonist tirzepatide (Mounjaro, Zepbound) was associated with greater weight loss, but also muscle loss, compared with semaglutide (Ozempic, Wegovy), according to a medical...
Read full article →The data, compiled by the Brookings Center on Health Policy, shows that average prices for some services like imaging were seven-times higher than Medicare prices.
Read full article →The Indianapolis-based insurer raised its 2026 earnings guidance after posting a better first quarter than Wall Street expected. Still, Elevance lodged a $935 million expense to cover what it might owe the CMS over faulty data reporting.
Read full article →A program that got caught up in HHS’ decision to abandon mRNA research was revived by a public-private coalition and is now beginning a large, late-stage test that could support a future approval.
Read full article →The company argues the offering is a more comprehensive approach to weight management, allowing patients to receive ongoing support care and transparent pricing on prescriptions.
Read full article →